Tirzepatide, activating both GLP-1 and GIP receptors, has a particularly strong effect on insulin resistance, which is relevant for women whose glucose metabolism has shifted significantly after menopause
IGF-1 LR3 is a lab-made version of the natural growth factor IGF-1, which works in the body much like insulin
People are reordering our Glyteine nearly as fast as we can make it
Many individuals with both conditions successfully use GLP-1 medications whilst managing their thyroid condition with levothyroxine replacement therapy
Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects
For the wider research view, see the Cagrilintide guide on how it works, study results, side effects, and legal status